China Approves First Domestically Produced Nine-Valent HPV Vaccine
4 Articles
4 Articles
China has announced a major medical breakthrough after the National Medical Products Administration approved the use of a domestically produced 9-valent HPV vaccine for the first time, making China the second country in the world to produce its own 9-valent HPV vaccine.
China approves first domestically produced nine-valent HPV vaccine
China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Wednesday, according to the National Medical Products Administration.The vaccine, Cecolin 9, has been jointly developed by the Xiang An Biomedicine Laboratory,
China’s Homegrown 9-Valent HPV Vaccine Expected to Boost Immunization Coverage
A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. (Photo/Xinhua) Beijing - China's drug regulator has approved the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine, ending over a decade of foreign dominance in the market. The vaccine, Cecolin 9, has been included on a…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium